share_log

Town Health International Medical Group's (HKG:3886) Strong Earnings Are Of Good Quality

Town Health International Medical Group's (HKG:3886) Strong Earnings Are Of Good Quality

城市健康國際醫療集團(HKG:3886)強勁的盈利質量良好
Simply Wall St ·  2022/05/04 18:56

Town Health International Medical Group Limited's (HKG:3886) earnings announcement last week was disappointing for investors, despite the decent profit numbers. Our analysis says that investors should be optimistic, as the strong profit is built on solid foundations.

城市健康國際醫療集團有限公司(HKG:3886)上週公佈的業績令投資者失望,儘管利潤數字不錯。我們的分析認為,投資者應該樂觀,因為強勁的利潤是建立在堅實的基礎上的。

View our latest analysis for Town Health International Medical Group

查看我們對城市健康國際醫療集團的最新分析

SEHK:3886 Earnings and Revenue History May 4th 2022
聯交所:3886盈利及收入歷史2022年5月4日

How Do Unusual Items Influence Profit?

不尋常的項目如何影響利潤?

For anyone who wants to understand Town Health International Medical Group's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by HK$37m due to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's hardly a surprise given these line items are considered unusual. Assuming those unusual expenses don't come up again, we'd therefore expect Town Health International Medical Group to produce a higher profit next year, all else being equal.

對於任何想要了解城市健康國際醫療集團超出法定數字的利潤的人來説,重要的是要注意到,在過去12個月中,由於不尋常的項目,法定利潤減少了3700萬港元。雖然最初由於不尋常的項目而扣除的金額令人失望,但也有一線希望。當我們分析全球絕大多數上市公司時,我們發現重大的不尋常項目往往不會重複。考慮到這些項目被認為是不尋常的,這並不令人驚訝。假設這些不尋常的支出不會再次出現,我們因此預計,在其他條件相同的情況下,城市健康國際醫療集團明年將產生更高的利潤。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Town Health International Medical Group.

注:我們總是建議投資者檢查資產負債表的實力。點擊此處查看我們對城市健康國際醫療集團的資產負債表分析。

Our Take On Town Health International Medical Group's Profit Performance

我們對城市健康國際醫療集團盈利表現的看法

Unusual items (expenses) detracted from Town Health International Medical Group's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Town Health International Medical Group's statutory profit actually understates its earnings potential! And it's also positive that the company showed enough improvement to book a profit this year, after losing money last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. In terms of investment risks, we've identified 2 warning signs with Town Health International Medical Group, and understanding these should be part of your investment process.

不尋常的項目(費用)減損了城市健康國際醫療集團去年的收益,但我們明年可能會看到改善。基於這一觀察,我們認為城市健康國際醫療集團的法定利潤很可能實際上低估了其盈利潛力!同樣積極的是,該公司在去年虧損後,表現出了足夠的改善,今年實現了盈利。歸根結底,如果你想正確地瞭解這家公司,除了以上幾個因素之外,考慮其他因素也是至關重要的。因此,如果你想更深入地研究這隻股票,考慮它面臨的任何風險是至關重要的。在投資風險方面,我們已經與城市健康國際醫療集團確定了兩個警告信號,瞭解這些信號應該是您投資過程的一部分。

This note has only looked at a single factor that sheds light on the nature of Town Health International Medical Group's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

這份報告只關注了一個因素,它揭示了城市健康國際醫療集團的利潤性質。但如果你有能力將注意力集中在細枝末節上,總會有更多的東西需要發現。一些人認為,高股本回報率是高質量企業的良好標誌。雖然這可能需要為您做一些研究,但您可能會發現免費擁有高股本回報率的公司的集合,或者是內部人士購買的有用的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎?保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
這篇由《華爾街日報》撰寫的文章本質上是籠統的。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。簡單地説,華爾街在提到的任何股票中都沒有頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論